Prognostic and predictive factors for breast cancer: Translating technology to oncology

被引：21

作者：

Hayes, DF ^{[1
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 08期

关键词：

D O I：

10.1200/JCO.2005.10.074

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1596 / 1597

页数：2

相关论文

共 8 条

[1] Abe O, 1998, LANCET, V352, P930
[2] Circulating and disseminated tumor cells
Braun, S
Naume, B
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1623 - 1626
[3] Clarke M, 1998, LANCET, V351, P1451
[4] UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years
Peto, R
Boreham, J
Clarke, M
Davies, C
Beral, V
[J]. LANCET, 2000, 355 (9217) : 1822 - 1822
[5] Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
Slamon, DJ
Leyland-Jones, B
Shak, S
Fuchs, H
Paton, V
Bajamonde, A
Fleming, T
Eiermann, W
Wolter, J
Pegram, M
Baselga, J
Norton, L
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) : 783 - 792
[6] Gene expression profiling of breast cancer: A new tumor marker
van't Veer, LJ
Paik, S
Hayes, DF
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1631 - 1635
[7] Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719
[8] Physician/patient decision aids for adjuvant therapy
Whelan, TJ
Loprinzi, C
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) : 1627 - 1630